Skip to search.
 FTSE 100 Down 0.33%

More On SKP.L

Quotes

Derivatives

  • Warrants
  • Investment Products

Charts

News & Info

  • Headlines
  • Company Events

Company

Analyst Coverage

Ownership

Financials

Skyepharma PLC (SKP.L)

-LSE Ticker: 3BFNB6/ISIN: GB00B3BFNB64
444.00 0.00(0.00%) 13 Jun 10:08
Prev Close:444.00
Open:444.00
Bid:N/A x 5000000
Ask:465.00 x 62000
1y Target Est:N/A
Beta:N/A
Next Earnings Date:N/A
Day's Range:444.00 - 444.00
52wk Range:249.25 - 486.25
Volume:8,648
Avg Vol (3m):316,620
Market Cap:469.80m
P/E (ttm):18.05
EPS (ttm):24.60
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in GBp.

Headlines

  • No Headlines available for SKP.L at this time.

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):N/A
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-16) :N/A
Quarterly EPS Est (0-00-31) :N/A
Mean Recommendation*:1.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Skyepharma PLC develops and sells oral and inhalation pharmaceutical products worldwide. The company’s inhalation products include flutiform, an inhalation drug for asthma; and Relvar Ellipta/Breo Ellipta, Anoro Ellipta, and Incruse Ellipta, ... more
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback